Recent cryo-EM studies even demonstrated that Tau fibrils extracted from AD brains have a core composed of R3, R4 and ten residues beyond the end of R4 (Fitzpatrick et al. 2017), suggesting that PHF6 might be the most valuable target for development of TAI. The gene discussed is MAPT; the disease is Alzheimer disease.